四川省成都市2013～2015年单病种定额付费实施效果分析  

Single disease quota payment in Chengdu city of Sichuan province from 2013 to 2015

作　　者：李佳瑾[1] 孙麟[1] 冯海欢[1] 滕世伟 

机构地区：[1]四川大学华西医院医保办公室,成都610041

出　　处：《中国循证医学杂志》2017年第11期1265-1268,共4页Chinese Journal of Evidence-based Medicine

基　　金：四川大学华西医院医院管理创新项目(编号:YB2017002)

摘　　要：目的分析成都市前列腺肥大(增生)和输尿管结石单病种定额付费的现状。方法对成都市2013~2015年实行单病种定额付费的前列腺肥大(增生)和输尿管结石两个病种的付费情况、手术人次、住院天数等进行分析。统计分析采用SPSS 16.0软件进行。结果四川省成都市2013~2015年在单病种定额标准没有变化的前提下,三级和二级医院的前列腺肥大(增生)和输尿管结石两个病种均为结余状态。从平均住院天数来看,前列腺肥大(增生)在三级和二级医院的平均住院天数均有所下降,差异均有统计学意义(P<0.05)。结论四川省成都市单病种定额付费的实施对于前列腺肥大(增生)和输尿管结石的费用控制起到一定作用。将来的研究应继续贯彻执行按病种付费的机制,探索合理的付费标准,加大对医院执行的监管,并对医院建立有效的激励机制。Objective To evaluate the implementation effects and problems about quota payment of specific diseases for hyperplasia prostate and ureteral calculi in Chengdu. Methods Payments, man-time of operation, and the lengths of hospitalization of hyperplasia prostate and ureteral calculi as quota payment of specific diseases in Chengdu from 2013 to 2015 were analyzed by using SPSS 16.0 software. Results Based on the standards of medical expense limitation in Chengdu unchanged, tertiary and secondary hospitals remained surplus with quota standards of single diseases unchanged. The average lengths of hospitalization of hyperplasia prostate and ureteral calculi in tertiary and secondary hospitals were significantly decreased （P〈0.05）. Conclusion The application of quota payment policy for single disease in Chengdu city of Sichuan province has been proved to work on controlling the medical expense of treating hyperplasia prostate and ureteral calculi. Our results indicate the continuous implementation of quota payment policy. However, the exploration of proper payment standardization, enhance of hospital supervision and establishment of efficient system are still needed to define.

关 键 词：单病种 按病种付费 实施效果 四川 

分 类 号：R197.323[医药卫生—卫生事业管理]